Jericho Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.76M Buy
24,405
+6,117
+33% +$1.27M 2.46% 21
2026
Q1
$4.11M Buy
18,288
+439
+2% +$109K 2.59% 22
2025
Q4
$4.3M Buy
17,849
+1,840
+11% +$471K 2.59% 21
2025
Q3
$4.38M Buy
16,009
+69
+0.4% +$18.8K 2.66% 20
2025
Q2
$4.11M Sell
15,940
-250
-2% -$59.6K 2.71% 18
2025
Q1
$3.62M Buy
16,190
+635
+4% +$148K 2.63% 21
2024
Q4
$3.56M Buy
+15,555
New +$3.75M 2.58% 20

Other funds holding RMD

Jericho Financial's RMD Position: Q2 2026 in Review

Jericho Financial increased its ResMed (RMD) stake by 33% in Q2 2026, buying an estimated $1.27M and bringing the position to 24,405 shares worth $4.76M. The position accounts for 2.46% of the portfolio, ranked #21.

Jericho Financial first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jericho Financial held 24,405 shares of ResMed worth $4.76M as of Q2 2026.
  • Jericho Financial bought 6,117 ResMed shares in Q2 2026, an estimated $1.27M.
  • ResMed made up 2.46% of Jericho Financial's portfolio in Q2 2026, its #21 holding.
  • Jericho Financial first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jericho Financial's 13F filing for Q2 2026, filed 13 Aug 2026.